Ryght, an innovator in generative AI (GenAI) technology for life science companies, announced a partnership with Lucem Health to deploy applications that incorporate Ryght's...
BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and...
Curia, a leading contract research, development and manufacturing organization, announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli...
Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, announced the appointment of Gregory Cole, PhD as Chief Innovation...
Evaxion Biotech A/S, a clinical research-focused biotechnology company specializing in the development of vaccines powered by AI-Immunology™, announces the success of the initial phases...
Absci Corporation, a data-first generative AI drug creation company, announced the initiation of IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody designed using...
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial...